Wednesday, November 5, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Stocks

Cbiz Stock: Markham Acquisition Boosts Profits Despite Headwinds

Dieter Jaworski by Dieter Jaworski
July 31, 2025
in Stocks
0
Cbiz Stock
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

Cbiz has exceeded profit expectations in the second quarter of 2025, reporting an adjusted earnings per share of $0.95, surpassing analyst estimates of $0.84 by 12.6%. This represents a remarkable 64% increase compared to the same period last year. However, the financial service provider fell slightly short of revenue projections, generating $684 million against forecasted $701.43 million. The 2024 Markham acquisition is proving to be a strategic masterstroke, with integration progressing ahead of schedule and expected to deliver synergies exceeding the initially targeted $25 million before 2026. The company’s adjusted EBITDA surged 128% to $66 million, improving margins to 17%.

Pricing Pressure Challenges Growth

For the first time in years, Cbiz faces pricing pressure, managing only 4% average price increases in the first half of 2025, down from the mid-to-high single-digit growth achieved in previous years. This reflects growing cost consciousness among mid-market clients amid economic uncertainties. The discretionary consulting business is particularly affected as clients postpone projects until economic conditions stabilize. Despite these challenges, Cbiz maintained its annual forecast of $2.8-2.95 billion in revenue and adjusted earnings per share of $3.60-3.65, though management now expects results to trend toward the lower end of these ranges as difficult market conditions persist.

Ad

Cbiz Stock: Buy or Sell?! New Cbiz Analysis from November 5 delivers the answer:

The latest Cbiz figures speak for themselves: Urgent action needed for Cbiz investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from November 5.

Cbiz: Buy or sell? Read more here...

Tags: Cbiz
Dieter Jaworski

Dieter Jaworski

About Dieter Jaworski From a numbers-obsessed child to creating his first investment newsletter. Even as a child, Dieter Jaworski's mother couldn't believe how fascinated he was with numbers. This early passion for mathematics and data analysis laid the foundation for a successful career in financial markets and investment analysis.
Areas of Expertise:
  • Quantitative Analysis
  • Financial Newsletter Publishing
  • Data-Driven Investment Strategies
  • Market Pattern Recognition
Dieter's unique approach combines his natural affinity for numbers with decades of market experience, providing investors with data-driven insights and practical investment strategies.

Related Posts

Royal Gold Stock
Stocks

Royal Gold Shares Surge to Record High on Acquisition Momentum

September 29, 2025
Unitedhealth Stock
Stocks

UnitedHealth Shares Present Conflicting Outlook for Investors

September 29, 2025
ASML Stock
Stocks

ASML Forges Strategic AI Alliance to Bolster Semiconductor Dominance

September 29, 2025
Next Post
Pitney Bowes Stock

Pitney Bowes Stock: Mixed Results Spark Leadership Change

Align Stock

Align Stock: Shares Plummet 35% After Disappointing Earnings

Duos Technologies Stock

Duos Technologies Stock: $40M Capital Raise Fuels Expansion

Recommended

Aclaris Therapeutics Stock

Aclaris Therapeutics Faces Critical Earnings Test Amid Steep Revenue Decline

4 days ago
Strategic Education Stock

Strategic Education Posts Impressive Quarterly Results, Beating Forecasts

2 months ago

China Liberal Education Holdings Limited Meets Nasdaqs Minimum Bid Price Requirement

2 years ago
Amazon Stock

Amazon Stock: Cloud Slowdown Sparks Investor Panic

3 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple Applovin BioNTech Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Nike NIO Nvidia Ocugen Opendoor Oracle Oxford Lane Capital Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Strong Earnings Fail to Lift AMD Shares

Broadcom Emerges as a Powerhouse in the Custom AI Chip Arena

Opendoor Shares Face Mounting Pressure Ahead of Q3 Earnings

Ocugen’s Critical Financial Report: What Investors Need to Watch

Intel Shares Face Critical Test After Sharp Decline

Analyst Upgrade Sparks Nestlé Share Revival

Trending

CureVac Stock
Mergers & Acquisitions

CureVac Shareholders Face Critical Acquisition Deadline

by Andreas Sommer
November 5, 2025
0

The biotechnology sector is watching closely as BioNTech's proposed acquisition of CureVac enters its decisive phase. With...

Iris Energy Stock

Microsoft’s $9.7 Billion Bet on Iris Energy’s AI Infrastructure

November 5, 2025
Volatus Aerospace Stock

Volatus Aerospace: A Corporate Overhaul Sets Stage for Potential Rebound

November 5, 2025
AMD Stock

Strong Earnings Fail to Lift AMD Shares

November 5, 2025
Broadcom Stock

Broadcom Emerges as a Powerhouse in the Custom AI Chip Arena

November 5, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • CureVac Shareholders Face Critical Acquisition Deadline
  • Microsoft’s $9.7 Billion Bet on Iris Energy’s AI Infrastructure
  • Volatus Aerospace: A Corporate Overhaul Sets Stage for Potential Rebound

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com